INTRODUCTION: Acute effects of incidental cardiac irradiation in patients treated for thoracic cancer are not well characterized. We evaluated longitudinal changes in cardiac biomarkers for patients undergoing conformal radiation therapy (RT) with thoracic malignancies with high-dose cardiac exposure. METHODS: Twenty-five patients enrolled in a prospective trial (February 2009-December 2012) received more than or equal to 45 Gy to the thorax, with pretreatment estimates of more than or equal to 20 Gy to the heart. Chemotherapy was allowed except for doxorubicin or fluorouracil. Electrocardiographic (ECG), troponin-I (TnI), and brain natriuretic peptide (BNP) measurements were obtained before RT, within 24 hours of the first fraction, at the end of RT, and at first follow-up (1-2 months). These biomarkers were quantified at specific times and changes from baseline were evaluated with paired t tests. RESULTS: The median heart dose was 25.9 Gy (range 10.1-35.1 Gy). After the first RT fraction, no changes were noted in ECG or median TnI or BNP levels; at the end of RT, two patients had elevated TnI and BNP, but neither difference was statistically significant. At first follow-up, TnI had returned to normal but the median BNP remained elevated (p = 0.042). BNP did not increase over time in the 18 patients who received only RT. Twelve patients experienced acute ECG changes during RT, which resolved in seven patients by the next measurement. No patients experienced clinically significant RT-related events. CONCLUSION: Increases in BNP and ECG changes were observed during high doses of radiation to the heart. The findings of this pilot study warrant further investigation and validation.
INTRODUCTION: Acute effects of incidental cardiac irradiation in patients treated for thoracic cancer are not well characterized. We evaluated longitudinal changes in cardiac biomarkers for patients undergoing conformal radiation therapy (RT) with thoracic malignancies with high-dose cardiac exposure. METHODS: Twenty-five patients enrolled in a prospective trial (February 2009-December 2012) received more than or equal to 45 Gy to the thorax, with pretreatment estimates of more than or equal to 20 Gy to the heart. Chemotherapy was allowed except for doxorubicin or fluorouracil. Electrocardiographic (ECG), troponin-I (TnI), and brain natriuretic peptide (BNP) measurements were obtained before RT, within 24 hours of the first fraction, at the end of RT, and at first follow-up (1-2 months). These biomarkers were quantified at specific times and changes from baseline were evaluated with paired t tests. RESULTS: The median heart dose was 25.9 Gy (range 10.1-35.1 Gy). After the first RT fraction, no changes were noted in ECG or median TnI or BNP levels; at the end of RT, two patients had elevated TnI and BNP, but neither difference was statistically significant. At first follow-up, TnI had returned to normal but the median BNP remained elevated (p = 0.042). BNP did not increase over time in the 18 patients who received only RT. Twelve patients experienced acute ECG changes during RT, which resolved in seven patients by the next measurement. No patients experienced clinically significant RT-related events. CONCLUSION: Increases in BNP and ECG changes were observed during high doses of radiation to the heart. The findings of this pilot study warrant further investigation and validation.
Authors: Maria P D'Errico; Luca Grimaldi; Maria F Petruzzelli; Emilio A L Gianicolo; Francesco Tramacere; Antonio Monetti; Roberto Placella; Giorgio Pili; Maria Grazia Andreassi; Rosa Sicari; Eugenio Picano; Maurizio Portaluri Journal: Int J Radiat Oncol Biol Phys Date: 2011-06-02 Impact factor: 7.038
Authors: Daniel R Gomez; Falk Poenisch; Chelsea C Pinnix; Tommy Sheu; Joe Y Chang; Nada Memon; Radhe Mohan; Marc A Rozner; Anne H Dougherty Journal: Int J Radiat Oncol Biol Phys Date: 2013-11-01 Impact factor: 7.038
Authors: Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall Journal: N Engl J Med Date: 2013-03-14 Impact factor: 91.245
Authors: Till Keller; Tanja Zeller; Dirk Peetz; Stergios Tzikas; Alexander Roth; Ewa Czyz; Christoph Bickel; Stephan Baldus; Ascan Warnholtz; Meike Fröhlich; Christoph R Sinning; Medea S Eleftheriadis; Philipp S Wild; Renate B Schnabel; Edith Lubos; Nicole Jachmann; Sabine Genth-Zotz; Felix Post; Viviane Nicaud; Laurence Tiret; Karl J Lackner; Thomas F Münzel; Stefan Blankenberg Journal: N Engl J Med Date: 2009-08-27 Impact factor: 91.245
Authors: Sukesh C Burjonroppa; Ann T Tong; Lian-Chun Xiao; Marcella M Johnson; S Wamique Yusuf; Daniel J Lenihan Journal: Am J Clin Oncol Date: 2007-06 Impact factor: 2.339
Authors: Biniyam G Demissei; Gary Freedman; Steven J Feigenberg; John P Plastaras; Amit Maity; Amanda M Smith; Caitlin McDonald; Karyn Sheline; Charles B Simone; Lilie L Lin; Joseph R Carver; Peter Liu; Liyong Zhang; Justin E Bekelman; Bonnie Ky Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-14 Impact factor: 7.038
Authors: Matthew J Ferris; Katherine S Martin; Jeffrey M Switchenko; Oluwatosin A Kayode; Jonathan Wolf; Quang Dang; Robert H Press; Walter J Curran; Kristin A Higgins Journal: Pract Radiat Oncol Date: 2019-05-09
Authors: Nicholas A Serrano; Ross Mikkelsen; Justin Canada; Eleonora Mezzaroma; Elisabeth Weiss; Antonio Abbate Journal: Int J Cardiol Date: 2016-08-15 Impact factor: 4.164
Authors: Ryne J DeBo; Cynthia J Lees; Greg O Dugan; David L Caudell; Kris T Michalson; David B Hanbury; Kylie Kavanagh; J Mark Cline; Thomas C Register Journal: Radiat Res Date: 2016-06-22 Impact factor: 2.841